These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 37494610

  • 1. OPG/RANK/RANKL Axis in Egyptian Children With Acute Lymphoblastic Leukemia After Maintenance Therapy: Relationship to Bone Mineral and Vitamin D Status.
    Hablas NM, Keshk WA.
    J Pediatr Hematol Oncol; 2023 Aug 01; 45(6):e733-e738. PubMed ID: 37494610
    [Abstract] [Full Text] [Related]

  • 2. OPG/RANK/RANKL signaling axis in patients with type I diabetes: Associations with parathormone and vitamin D.
    Karalazou P, Ntelios D, Chatzopoulou F, Fragou A, Taousani M, Mouzaki K, Galli-Tsinopoulou A, Kouidou S, Tzimagiorgis G.
    Ital J Pediatr; 2019 Dec 10; 45(1):161. PubMed ID: 31823791
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. SERUM LEVELS OF FIBROBLAST GROWTH FACTOR-23, OSTEOPROTEGERIN, AND RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B LIGAND IN PATIENTS WITH PROLACTINOMA.
    Arslan MS, Sahin M, Karakose M, Tutal E, Topaloglu O, Ucan B, Demirci T, Caliskan M, Ozdemir S, Ozbek M, Cakal E.
    Endocr Pract; 2017 Mar 10; 23(3):266-370. PubMed ID: 27849387
    [Abstract] [Full Text] [Related]

  • 7. The role of magnesium in the pathogenesis of osteoporosis.
    Liu L, Luo P, Wen P, Xu P.
    Front Endocrinol (Lausanne); 2024 Mar 10; 15():1406248. PubMed ID: 38904051
    [Abstract] [Full Text] [Related]

  • 8. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease.
    García-Valdecasas-Campelo E, González-Reimers E, Santolaria-Fernández F, De la Vega-Prieto MJ, Milena-Abril A, Sánchez-Pérez MJ, Martínez-Riera A, Gómez-Rodríguez Mde L.
    Alcohol Alcohol; 2006 Mar 10; 41(3):261-6. PubMed ID: 16476762
    [Abstract] [Full Text] [Related]

  • 9. [The relationships between changes of serum osteoprotegerin, nuclear factor-kappa B ligand receptor activator, and age, menopause, bone biochemical markers and bone mineral densities in women aged 20 - 75].
    Liu JM, Zhao HY, Ning G, Zhao YJ, Chen Y, Zhang LZ, Xu MY, Chen JL.
    Zhonghua Nei Ke Za Zhi; 2004 Jun 10; 43(6):447-50. PubMed ID: 15312444
    [Abstract] [Full Text] [Related]

  • 10. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
    Stilgren LS, Rettmer E, Eriksen EF, Hegedüs L, Beck-Nielsen H, Abrahamsen B.
    Bone; 2004 Jul 10; 35(1):256-65. PubMed ID: 15207766
    [Abstract] [Full Text] [Related]

  • 11. The receptor activator of nuclear factor κΒ ligand receptor leucine-rich repeat-containing G-protein-coupled receptor 4 contributes to parathyroid hormone-induced vascular calcification.
    Carrillo-López N, Martínez-Arias L, Alonso-Montes C, Martín-Carro B, Martín-Vírgala J, Ruiz-Ortega M, Fernández-Martín JL, Dusso AS, Rodriguez-García M, Naves-Díaz M, Cannata-Andía JB, Panizo S.
    Nephrol Dial Transplant; 2021 Mar 29; 36(4):618-631. PubMed ID: 33367746
    [Abstract] [Full Text] [Related]

  • 12. Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts.
    Armada L, Marotta Pdos S, Pires FR, Siqueira JF.
    J Endod; 2015 Aug 29; 41(8):1281-7. PubMed ID: 25956608
    [Abstract] [Full Text] [Related]

  • 13. The effect of RANKL and OPG on bone mineral density in pre-dialysis chronic renal failure.
    Fahrleitner-Pammer A, Dobnig H, Dimai HP, Holzer H, Benesch T, Borchhardt K, Cejka D, Haas M.
    Clin Nephrol; 2009 Jun 29; 71(6):652-9. PubMed ID: 19473634
    [Abstract] [Full Text] [Related]

  • 14. Effects of dietary calcium to available phosphorus ratios on bone metabolism and osteoclast activity of the OPG /RANK/RANKL signalling pathway in piglets.
    Zhao L, Li M, Sun H.
    J Anim Physiol Anim Nutr (Berl); 2019 Jul 29; 103(4):1224-1232. PubMed ID: 31062421
    [Abstract] [Full Text] [Related]

  • 15. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?
    Avbersek-Luznik I, Balon BP, Rus I, Marc J.
    Nephrol Dial Transplant; 2005 Mar 29; 20(3):566-70. PubMed ID: 15665031
    [Abstract] [Full Text] [Related]

  • 16. Serum RANKL, osteoprotegerin (OPG) and RANKL/OPG ratio in children with systemic lupus erythematosus.
    Ali R, Hammad A, El-Nahrery E, Hamdy N, Elhawary AK, Eid R.
    Lupus; 2019 Sep 29; 28(10):1233-1242. PubMed ID: 31403902
    [Abstract] [Full Text] [Related]

  • 17. Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms.
    Eid R, Abdelsalam M, Fathy AA, Abolenein HM, Elmarghany EB, El-Hanafy AA, Hamdy N, Abd-Elmagid DS, Niazy NA, Abd-El Ghaffar DM.
    Pediatr Rheumatol Online J; 2023 Jun 16; 21(1):58. PubMed ID: 37328895
    [Abstract] [Full Text] [Related]

  • 18. Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease.
    Doumouchtsis K, Perrea D, Doumouchtsis S, Tziamalis M, Poulakou M, Vlachos I, Kostakis A.
    Ther Apher Dial; 2009 Feb 16; 13(1):49-55. PubMed ID: 19379170
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.